Home

David Malcom Rodman, Chief Medical Officer: Mineralys Therapeutics MLYS Sell · Filed 24/07/18

Trade details

Type
Insider sale
Amount
$7,875
Shares · price
525 sh · $15.00 a share
Held after
102,873 sh
Trade date
24/07/16
Filed
24/07/18
Days to filing
2 days

Sold 0.5% of holdings

Share of holding sold
0.5%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 24/06/16~24/08/15

David Malcom Rodman's recent trades

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $11.7K

    Filed 09/17

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $216.9K

    Filed 09/14

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $67K

    Filed 09/09

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $10.6K

    Filed 08/17

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $372.2K

    Filed 08/13